Advertisement

Clinical Experience in Children

  • Y. de Prost

Abstract

Atopic dermatitis in children has become an important public health concern. The prevalence of the condition has trebled in the past 20 years, reaching 15%–20% in Western countries [16], and this continuing upward rise shows no signs of being reversed. Atopic dermatitis affects primarily infants and children, with the age of onset typically between 3 and 6 months old, and this is one of the major challenges in contemporary paediatric dermatology.

Keywords

Atopic Dermatitis Severe Atopic Dermatitis Skin Atrophy Tacrolimus Ointment Topical Tacrolimus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aly R (1980) Bacteriology of atopic dermatitis. Acta Derm Venerol (Stockh) Suppl 92: 16–18Google Scholar
  2. 2.
    Bekersky I, Fitzsimmons W, Tanase A et al. (2001) Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol 44(1): S17–27PubMedCrossRefGoogle Scholar
  3. 3.
    Bode HH (1980) Dwarfism following long-term topical corticosteroid therapy. JAMA 244: 813–814PubMedCrossRefGoogle Scholar
  4. 4.
    Boguniewicz M, Fiedler VC, Raimer S et al. (1998) A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 102: 637–644PubMedCrossRefGoogle Scholar
  5. 5.
    Bos J, Smitt S (1996) Atopic dermatitis. J Eur Acad Dermatol Venereol 7: 101–114CrossRefGoogle Scholar
  6. 6.
    Bridgett C, Noren P, Staughton R (1996) Atopic skin disease. A manual for practitioners. Wrightson Biomedical Publishing, PetersfieldGoogle Scholar
  7. 7.
    Drake L, Prendergast M, Maher R et al. (2001) The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 44: S65–72PubMedCrossRefGoogle Scholar
  8. 8.
    Gunther S (1976) Incidence and degree of unwanted adverse effects of corticoids in children: results of dermatological studies in children with chronic diseases in the age group of 1–15 years. Z Hautkr 51: 569–579PubMedGoogle Scholar
  9. 9.
    Hanifin JM, Thurston M, Omoto M et al. (2001) The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 10: 11–18PubMedCrossRefGoogle Scholar
  10. 10.
    Hanifin J, Leung D, Palier A, Rico MJ (2003) Tacrolimus ointment monotherapy is safe and effective for the long-term treatment [more than 3 years] of atopic dermatitis in pediatric patients. 59th Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Denver, USA, March 7–12, abstractGoogle Scholar
  11. 11.
    Harris JM, Cullinan P, Williams HC et al. (2001) Environmental associations with eczema in early life. Br J Dermatol 144: 795–802PubMedCrossRefGoogle Scholar
  12. 12.
    Hepburn D, Yohn JJ, Weston WL (1994) Topical steroid treatment in infants, children and adolescents. Adv Dermatol 9: 225–254; discussion 255PubMedGoogle Scholar
  13. 13.
    Hill CJ, Rosenberg A Jr (1978) Adverse effects from topical steroids. Cutis 21: 624–628PubMedGoogle Scholar
  14. 14.
    Kang S, Lucky A, Pariser D et al. (2001) Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 44: S58–64PubMedCrossRefGoogle Scholar
  15. 15.
    Kawashima M, Harada S, Tamaki K (1997) A safety study of FK506 ointment in patients with atopic dermatitis. J Clin Ther Med 13: 1483–1492Google Scholar
  16. 16.
    Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG (1994) The prevalence of childhood eczema in a general population. J Am Acad Dermatol 30: 35–39PubMedCrossRefGoogle Scholar
  17. 17.
    Lewis-Jones MS, Finlay AY (1994) The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Clin Exp Dermatol 19: 210–216CrossRefGoogle Scholar
  18. 18.
    McLean C, Lobo R, Brazier D (1995) Cataracts, glaucoma, femoral avascular necrosis caused by topical corticosteroid ointment. Lancet 346: 1298PubMedGoogle Scholar
  19. 19.
    Nakagawa H, Etoh T, Ishibashi Y et al. (1994) Tacrolimus ointment for atopic dermatitis. Lancet 344: 883PubMedCrossRefGoogle Scholar
  20. 20.
    Ngheim P, Pearson G, Langley R (2002) Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 46: 228–241CrossRefGoogle Scholar
  21. 21.
    Palier A, Eichenfield LF, Leung IYM et al. (2001) A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatrie patients. J Am Acad Dermatol 44: S47–57CrossRefGoogle Scholar
  22. 22.
    de Prost Y, Bodemer C, Teillac D (1989) Double-blind randomized placebo-controlled trial of local cyclosporine in atopic dermatitis. Arch Dermatol 125: 570PubMedCrossRefGoogle Scholar
  23. 23.
    Queille C, Pommarede R, Saurat JH (1984) Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1: 246–253PubMedCrossRefGoogle Scholar
  24. 24.
    Raimer SS (2000) Managing pediatrie atopic dermatitis. Clin Pediatr 39: 1–14CrossRefGoogle Scholar
  25. 25.
    Reitamo S, Rissanen J, Remitz A et al. (1998) Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 111: 396–398PubMedCrossRefGoogle Scholar
  26. 26.
    Reitamo S, van Leent EJM, Ho V et al. for the European Tacrolimus Ointment Study Group (2002) Efficacy and safety of tacrolimus ointment compared with hydrocortisone acetate in children with atopic dermatitis. J Allergy Clin Immunol 109: 539–546PubMedCrossRefGoogle Scholar
  27. 27.
    Remitz A, Kyllonen H, Granlund H, Reitamo S (2001) Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 107: 196–197PubMedCrossRefGoogle Scholar
  28. 28.
    de Rie MA, Meinardi MMHM, Bos JD (1991) Lack of effect of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis. Acta Derm Venereol 71: 452–454PubMedGoogle Scholar
  29. 29.
    Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C (1982) Cushing’s syndrome after topical application of corticosteroid. Am J Dis Child 136: 247–275Google Scholar
  30. 30.
    Stiehm ER, Roberts RL, Kaplan MS, Jonathan Corren J, Rico MJ, Parker JC (2003) Tacrolimus ointment does not alter the immune system of children aged 2–12. 59th Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Denver, USA, March 7–12, abstractGoogle Scholar
  31. 31.
    Undre NA, Stevenson P, Schafer A (1999) Pharmacokinetics of tacrolimus: clinically relevant aspects. Transplant Proc 31: 7A 21S–24SPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Y. de Prost

There are no affiliations available

Personalised recommendations